CN Patent

CN114502187A — 一种肽酰胺类组合物及其制备

Assigned to Haisco Pharmaceutical Group Co Ltd · Expires 2022-05-13 · 4y expired

What this patent protects

本发明公开一种肽酰胺类化合物组合物及其制备方法，及其医药上的用途，具体为含有式(I)结构化合物及pH调节剂，溶液pH值为3～5.5。组合物稳定、辅料种类少，临床使用稳定。

USPTO Abstract

本发明公开一种肽酰胺类化合物组合物及其制备方法，及其医药上的用途，具体为含有式(I)结构化合物及pH调节剂，溶液pH值为3～5.5。组合物稳定、辅料种类少，临床使用稳定。

Drugs covered by this patent

Patent Metadata

Patent number
CN114502187A
Jurisdiction
CN
Classification
—
Expires
2022-05-13
Drug substance claim
No
Drug product claim
No
Assignee
Haisco Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.